HISTATEK LLC has a total of 50 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are WIESER RAIMUND J, LEUKOLECT AS and CHEMOKINE THERAPEUTICS CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | Brazil | 6 | |
#3 | Canada | 6 | |
#4 | China | 5 | |
#5 | WIPO (World Intellectual Property Organization) | 5 | |
#6 | EPO (European Patent Office) | 4 | |
#7 | Israel | 4 | |
#8 | Mexico | 4 | |
#9 | Norway | 3 | |
#10 | Hong Kong | 2 | |
#11 | Indonesia | 1 | |
#12 | Japan | 1 | |
#13 | United States | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Clagett James | 23 |
#2 | Palmer Craig | 13 |
#3 | Houck John C | 11 |
#4 | Clagett James A | 7 |
#5 | Lipani John | 5 |
#6 | Clargett James | 4 |
#7 | Clagett J | 3 |
#8 | James Clagett | 2 |
#9 | Lipani J | 1 |
#10 | Clargett J | 1 |
Publication | Filing date | Title |
---|---|---|
AU2004214552A1 | Treatment with small peptides to effect antifibrotic activity | |
IL152922D0 | Complexes of alpha-6 integrin subunits with small peptides and methods for treating indications resulting from modulation of integrin-mediated responses by altering signal transduction | |
AU8014200A | N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent | |
AU6351500A | Small peptides and methods for downregulation of ige | |
AU3765100A | Treatment with small peptides to effect antifibrotic activity | |
AU1801899A | Small peptides and methods for treatment of asthma and inflammation | |
AU8477998A | Small peptides and methods for treatment of asthma and inflammation |